Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zdeňka Vernerová"'
Autor:
Lucie Andrés Cerezo, Markéta Kuklová, Hana Hulejová, Zdeňka Vernerová, Nikola Kaspříková, David Veigl, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt
Publikováno v:
Mediators of Inflammation, Vol 2015 (2015)
Objective. Progranulin (PGRN) is implicated in the pathogenesis of rheumatoid arthritis (RA). The aim of this study was to assess the relationship between PGRN and disease activity in RA. Methods. PGRN levels were evaluated in patients with RA (n=47)
Externí odkaz:
https://doaj.org/article/f44dd494df9f449b9ffb08f22b72deb1
Autor:
Ivana Vaněčková, Silvie Hojná, Zdenka Vernerová, Michaela Kadlecová, Hana Rauchová, Elzbieta Kompanowska-Jezierska, Zdeňka Vaňourková, Luděk Červenka, Josef Zicha
Publikováno v:
Frontiers in Physiology, Vol 10 (2019)
ObjectiveOur previous study in heterozygous Ren-2 transgenic rats (TGR) demonstrated that long-term treatment with endothelin receptor A (ETA) blocker atrasentan added to the renin-angiotensin system (RAS) blockade had renoprotective effects in a mod
Externí odkaz:
https://doaj.org/article/8daa08cb54f64a98ac0962f6e60ea410
Autor:
Jaroslav Hrdlička, Jan Neckář, František Papoušek, Zuzana Husková, Soňa Kikerlová, Zdenka Vaňourková, Zdenka Vernerová, Firat Akat, Jana Vašinová, Bruce D. Hammock, Sung Hee Hwang, John D. Imig, John R. Falck, Luděk Červenka, František Kolář
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Epoxyeicosatrienoic acids (EETs) and their analogs have been identified as potent antihypertensive compounds with cardio- and renoprotective actions. Here, we examined the effect of EET-A, an orally active EET analog, and c-AUCB, an inhibitor of the
Externí odkaz:
https://doaj.org/article/c98a38c7fda04e4a81194d59e2fbbc8c